Literature DB >> 31314997

Fulvestrant for the Treatment of Pulmonary Arterial Hypertension.

Steven M Kawut1, Diane Pinder1, Nadine Al-Naamani1, Amber McCormick1, Harold I Palevsky1, Jason Fritz1, K Akaya Smith1, Jeremy A Mazurek1, Margaret F Doyle2, Margaret R MacLean3, Angela DeMichele1, David A Mankoff1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31314997      PMCID： PMC6945473          DOI： 10.1513/AnnalsATS.201904-328RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  15 in total

1.  Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.

Authors:  Xinping Chen; Eric D Austin; Megha Talati; Joshua P Fessel; Eric H Farber-Eger; Evan L Brittain; Anna R Hemnes; James E Loyd; James West
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.

Authors:  Grayson L Baird; Christine Archer-Chicko; R Graham Barr; David A Bluemke; Andrew E Foderaro; Jason S Fritz; Nicholas S Hill; Steven M Kawut; James R Klinger; Joao A C Lima; Christopher J Mullin; Pamela Ouyang; Harold I Palevsky; Amy J Palmisicano; Diane Pinder; Ioana R Preston; Kari E Roberts; K Akaya Smith; Thomas Walsh; Mary Whittenhall; Corey E Ventetuolo
Journal:  Eur Respir J       Date:  2018-06-28       Impact factor: 16.671

3.  Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.

Authors:  Xinping Chen; Megha Talati; Joshua P Fessel; Anna R Hemnes; Santhi Gladson; Jaketa French; Sheila Shay; Aaron Trammell; John A Phillips; Rizwan Hamid; Joy D Cogan; Elliott P Dawson; Kristie E Womble; Lora K Hedges; Elizabeth G Martinez; Lisa A Wheeler; James E Loyd; Susan J Majka; James West; Eric D Austin
Journal:  Circulation       Date:  2015-10-20       Impact factor: 29.690

4.  Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension.

Authors:  Kewal Asosingh; Samar Farha; Alan Lichtin; Brian Graham; Deepa George; Micheala Aldred; Stanley L Hazen; James Loyd; Rubin Tuder; Serpil C Erzurum
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

5.  Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension.

Authors:  Joshua P Fessel; Xinping Chen; Andrea Frump; Santhi Gladson; Tom Blackwell; Christie Kang; Jennifer Johnson; James E Loyd; Anna Hemnes; Eric Austin; James West
Journal:  Pulm Circ       Date:  2013-12-02       Impact factor: 3.017

Review 6.  18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications.

Authors:  Geraldine J Liao; Amy S Clark; Erin K Schubert; David A Mankoff
Journal:  J Nucl Med       Date:  2016-06-15       Impact factor: 10.057

7.  Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.

Authors:  Corey E Ventetuolo; Grayson L Baird; R Graham Barr; David A Bluemke; Jason S Fritz; Nicholas S Hill; James R Klinger; Joao A C Lima; Pamela Ouyang; Harold I Palevsky; Amy J Palmisciano; Ipsita Krishnan; Diane Pinder; Ioana R Preston; Kari E Roberts; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

8.  Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.

Authors:  Steven M Kawut; Christine L Archer-Chicko; Angela DeMichele; Jason S Fritz; James R Klinger; Bonnie Ky; Harold I Palevsky; Amy J Palmisciano; Mamta Patel; Diane Pinder; Kathleen J Propert; K Akaya Smith; Frank Stanczyk; Russell Tracy; Anjali Vaidya; Mary E Whittenhall; Corey E Ventetuolo
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

9.  Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis.

Authors:  Haruchika Masuda; Christoph Kalka; Tomono Takahashi; Miyoko Yoshida; Mika Wada; Michiru Kobori; Rie Itoh; Hideki Iwaguro; Masamichi Eguchi; Yo Iwami; Rica Tanaka; Yoshihiro Nakagawa; Atsuhiko Sugimoto; Sayaka Ninomiya; Shinichiro Hayashi; Shunichi Kato; Takayuki Asahara
Journal:  Circ Res       Date:  2007-07-26       Impact factor: 17.367

10.  Derivatization enhances analysis of estrogens and their bioactive metabolites in human plasma by liquid chromatography tandem mass spectrometry.

Authors:  Nina Denver; Shazia Khan; Ioannis Stasinopoulos; Colin Church; Natalie Zm Homer; Margaret R MacLean; Ruth Andrew
Journal:  Anal Chim Acta       Date:  2018-12-21       Impact factor: 6.558
View more
  6 in total

1.  Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension.

Authors:  Grayson L Baird; Thomas Walsh; Jason Aliotta; Melissa Allahua; Ruth Andrew; Ghada Bourjeily; Alexander S Brodsky; Nina Denver; Mark Dooner; Elizabeth O Harrington; James R Klinger; Margaret R MacLean; Christopher J Mullin; Mandy Pereira; Athena Poppas; Mary Whittenhall; Corey E Ventetuolo
Journal:  Ann Am Thorac Soc       Date:  2021-02

Review 2.  Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Sasha Z Prisco; Thenappan Thenappan; Kurt W Prins
Journal:  JACC Basic Transl Sci       Date:  2020-12-28

Review 3.  Sex Differences in Pulmonary Hypertension.

Authors:  Juan José Rodriguez-Arias; Ana García-Álvarez
Journal:  Front Aging       Date:  2021-10-04

4.  A pilot study to examine association of BMI with functional class and 6 min walk distance in idiopathic and heritable PAH: Possible association with estrogen metabolism.

Authors:  Margaret R MacLean; Divya Pandya; Emilia M Swietlik; Nina Denver; Kirsty Mair; Nicholas W Morrell; Stefan Gräf
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

Review 5.  Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension.

Authors:  Kirsty M Mair; Rosemary Gaw; Margaret R MacLean
Journal:  Pulm Circ       Date:  2020-09-18       Impact factor: 3.017

6.  Association of premature menopause with incident pulmonary hypertension: A cohort study.

Authors:  Michael C Honigberg; Aniruddh P Patel; Tim Lahm; Malissa J Wood; Jennifer E Ho; Puja Kohli; Pradeep Natarajan
Journal:  PLoS One       Date:  2021-03-10       Impact factor: 3.752
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.